In North America there are two generally recognized pathotypes (pathotypes 1 and 2) of the fungus Entomophaga grylli which show host-preferential infection of grasshopper subfamilies. Pathotype 3, discovered in Australia, has a broader grasshopper host range and was considered to be a good biocontrol agent.
Current widely publicized problems with synthetic chemical insecticides have given rise to a sense of urgency in the development of biological control agents as supplements or alternatives to these chemicals. Chemical control is not only often environmentally harsh but also at times ineffective; in 1987 chemical pesticides failed to control an outbreak of grasshoppers in the western United States. The application of non-native strains of entomopathogenic fungi offers tremendous potential in pest control but also demands a careful and responsible approach. There is a perception that non-native strains may behave very differently from native strains. One particular example that has aroused controversy is the release of an Australian pathotype of the entomopathogenic fungus Entomophaga grylli into the United States for the control of grasshopper populations (1) (2) (3) . The perceived benefits of introducing foreign insect pathogens into the United States (3) has potential risks which include inhibition of natural pathogen effectiveness, possible threat to nontargeted organisms, loss of biological diversity, and disruption of food chains (1, 2) .
There are three generally recognized pathotypes of E. grylli, all apparently specific pathogens of grasshoppers but with different grasshopper subfamily host ranges (4) . The (6) . The lack of basic information on the establishment, spread, host range, and epidemiology of the Australian pathotype (1, 2, 7) resulted in a decision to discontinue grasshopper control trials with exotic organisms (7) . The inability to distinguish the Australian pathotype from endemic North American E. grylli pathotypes precluded a testable prediction of its effects on grasshopper populations and nontarget insects. Grasshoppers infected by E. grylli typically exhibit "summit disease syndrome," characterized by their clinging to elevated surfaces, such as stalks of wheat, prior to death (6) . However, no morphological characters (resting spores, conidia, hyphal bodies) are adequate for separating the three pathotypes (8) (9) (10) . In retrospect, we constructed cloned DNA fragments as pathotype-specific probes (11) to allow positive identification of the three E. grylli pathotypes at two release sites and surrounding areas during the three years (1992) (1993) (1994) release sites (12) and analyzed for E. grylli infection by using the pathotype-specific probes.
Construction of Pathotype-Specific DNA Probes. The construction ofE. grylli pathotype-specific cloned DNA probes has been reported (11) .
Fracturing of Resting Spores and Extraction of DNA. To extract DNA from resting spores in dead grasshoppers the infected grasshopper was placed in 0.5 ml of 10 mM Tris/1 mM EDTA buffer (pH 7.5) in a 2.2-ml Eppendorf tube. Nymphal grasshoppers were homogenized whole, whereas the abdomens of adult grasshoppers were homogenized. Each sample was homogenized (Tissue Tearor, model 985-370, variable speed, setting 5, 30,000 rpm; Biospec Products, Inc.) on ice three times for 10 sec with a 5-sec interval between pulses.
DNA was extracted twice with an equal volume of phenol/ chloroform and precipitated with 0.1 volume of 3 M sodium acetate and 1 volume of 2-propanol. The mixture was centrifuged and the pellet was washed with ice-cold 70% ethanol. The DNA pellet was resuspended in 100,ul of Tris/EDTA (pH 7.5) buffer. DNA was denatured with 40 .lI of 1 M NaOH and incubated for 10 min at room temperature. Then 170 ,ul of 0.125 NaOH/0.125X standard saline citrate was added for a final volume of 310 Al. DNA (100 ,ul) was blotted onto nitrocellulose membranes in triplicate and each membrane was hybridized with a radiolabeled pathotype-specific DNA probe.
Bioassay of Pathotype 3 in Field-Collected Grasshoppers. Fifth-instar grasshoppers were collected for bioassay from McKenzie County, North Dakota, and surrounding areas in 1989-1991. Field-collected grasshoppers were housed in cages and fed wheat bran for 10 days prior to bioassay. Twenty-five grasshoppers in each of 12 species collected were injected with 104 protoplasts in 10 lI of Grace's insect tissue culture medium (12) . Grasshoppers were checked daily for mortality. Dead grasshoppers were placed on water agar and checked for conidia formation within 24 hr of death. They were also dissected to determine whether resting spores were present in the body cavity. Table 2 ). n is the sample size. 
RESULTS

DISCUSSION
We have utilized pathotype-specific probes for the entomopathogenic fungus E. grylli (11) in order to monitor the establishment of an Australian pathotype 3 introduced into North Dakota between 1989 and 1991. Our results suggest that pathotype 3 caused substantial infection (-23% of E. grylliinfected grasshoppers) in 1992, but in 1993 infection declined to <2% and no pathotype 3 infections were found in 1994. Molecular markers have previously been used to identify an exotic entomopathogenic fungus in North America (13) . Entomophaga maimaiga, an Asian fungus, was identified as the causative agent for gypsy moth epizootics in eastern North America, and the geographical range of this fungus is increasing (13) . These studies show that molecular probes are powerful tools for epizootiological studies involving biocontrol agents. tA measure of E. grylli-infected grasshopper frequency; H, high (>100 E. grylli-infected grasshoppers collected); M, medium (<100 but >20); L, low (<20 The ecological principles implicated in the possible failure of pathotype 3 to establish in North. America have been outlined by Lockwood (1); these include competitive exclusion, invasion ecology, and community resistance to perturbation. The differential susceptibility among grasshopper species to E. grylli infections and any changes in the species mixes may affect the frequency of occurrence of pathotype 3. Grasshopper species densities and the phenology of occurrence, in addition to their ratios, could play a role in pathotype-specific infections of grasshoppers from the field. Migrant grasshoppers infected by pathotype 1 or 2 would further dilute the effects of pathotype 3. Despite optimistic arguments for the establishment of exotic biological control agents of grasshoppers in North America (3), the relative frequency of pathotype 3 has declined to levels so low that its maintenance in North Dakota may be difficult without more releases. Even if pathotype 3 resting spores are able to persist in soils and through winters in North Dakota, its future impact on suppression of grasshopper populations to a greater extent than pathotypes 1 and 2 would probably be minimal since biological control that is based on a rare species is likely to be ineffective (14) .
Coinfections of pathotype 1 or 2 with pathotype 3 were observed. The technique we employed cannot distinguish between an infection by a recombinant strain from an infection derived by two separate pathotypes. The formation of stable recombinant strains could have an adverse impact on the viability and continuation of native pathotypes, the loss of which could severely affect the prairie ecosystem (1, 2). However, E. grylli resting spores are formed by azygosporogenesis (15) with no apparent sexual recombination, precluding the possibility of recombinant strains. Pathotypes 1 and 2 appear to be separated with respect to host coinfection since there was only one incident of coinfection by these pathotypes. Host-specific cuticular cues, phenology of infection, and competitive exclusion are some of the factors that may be responsible for separating pathotype 1 from pathotype 2 in host grasshoppers. As expected, pathotypes 1 and 2 showed host preferences for oedipodine and melanopline grasshoppers, respectively, but host switching was detected in nature. We also showed that, in the field, gomphocerine grasshoppers were preferentially infected by pathotype 1.
Lockwood (1, 2) expressed concern that pathotype 3 may infect "beneficial" grasshoppers or suppress certain grasshopper species, resulting in the disruption of the local prairie ecosystem. M. femurrubrum is an intermediate host of a parasite of several native bird species, and suppression of this grasshopper species on a large scale could have ecological impacts (1) . In 1992, half of the E. grylli-infected M. femurrubrum were infected by pathotype 3. This could represent some ground for concern if large populations of this grasshopper were present. However, only 12 E. grylli-infected M. femurrubrum were collected. No E. grylli-infected H. viridis were found in the field. This grasshopper is viewed as a beneficial species because it feeds on a noxious weed, snakeweed (1, 7). Snakeweed was not common at either site and the H. viridis that were bioassayed in the laboratory were collected "10 km from the field release sites. Under laboratory conditions, this grasshopper was the only species tested that was not infected by pathotype 3 . The host range of pathotype 3 was broader in the laboratory (physiological host range) than in the field (ecological host range). Physiological and ecological host ranges of entomopathogenic fungi may differ, and caution should be exercised when extrapolating laboratory bioassay results to potential infections in the field.
In light of the controversy surrounding the introduction of the exotic strain, the failure of pathotype 3 to establish in 1993 and 1994 after a relatively high infection in 1992 is one of the best possible outcomes in this biological control trial. Persistence of pathotype 3 could result in ecological disruption of the prairie community (1, 2). However, previous to its decline, epizootics caused by pathotype 3 in 1992 may be, in part, responsible for the recent decrease in grasshopper populations (16) 
